NCT00020540View on ClinicalTrials.gov

Biological Therapy in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

March 31, 2001

Conditions
Kidney CancerMelanoma (Skin)
Interventions
BIOLOGICAL

recombinant CD40-ligand

BIOLOGICAL

recombinant flt3 ligand

Trial Locations (1)

20892

Surgery Branch, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00020540 - Biological Therapy in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer | Biotech Hunter | Biotech Hunter